Commercial flooring manufacturer James Halstead (LON:JHD) rolled out resilient FY26 results in the face of challenging market conditions and cost headwinds arising from the Iran conflict. A testing year to June 2026 also saw James Halstead cope with the collapse of major distributor client Headlam.
Why did the shares rally today? Well, James Halstead issued a cautiously optimistic outlook statement. And the AIM-listed flooring distributor also increased the annual dividend by 1.7% to a record 8.95p.
The uplift in the payout was modest. However, it marked the 50th consecutive year of dividend growth from the Bury-based group.
Showing resilience
FY26 results revealed a 12.7% drop in adjusted pre-tax profits to £48.2 million, in line with the guidance given with July’s profit warning. Sales decreased from £262 million to £259.9 million, largely driven by headwinds in Europe.
Management highlighted a sales slowdown driven by the disruption caused by Headlam’s cash flow difficulties.
But Headlam has now been broken up with some core assets sold to another customer, Likewise (LON:LIKE). And this should bring some stability back to the market.
What did the CEO say?
‘Our ongoing expectations are for increased sales in the UK as spending on education, prisons, health care and aged care, particularly refurbishment, picks up,’ said CEO Gordon Oliver.
‘Additionally, we continue to increase our direct export sales and are confident that our overseas business can increase profitability.’
| FY26A | FY27E | FY28E | |
| Revenue (£m) | 259.9 | 273 | 281.2 |
| Pre-tax profit (£m) | 48.2 | 50.1 | 52 |
| DPS (p) | 9 | 9.1 | 9.3 |
Source: James Halstead, Zeus
Panmure Liberum reiterated its ‘buy’ recommendation and 320p target price for James Halstead: ‘In our opinion, the quality of a business is demonstrated by its ability to navigate turbulent markets,’ said the broker.
‘In this regard, James Halstead continues to score well, validating our positive stance on the stock. Moreover, the high and sustainable ROIC and the scope to further expand international sales provide additional layers to the James Halstead story.’
Zeus commented: ‘FY26 demonstrates that earnings are not immune to the cycle, but resilient margins, strong cash generation and balance sheet set Halstead apart from more cyclical building products peers.’
James Halstead showcased the resilience of its business model in a tough FY26. And the firm continues to benefit from geographic diversification and a strong balance sheet.
Oliver expects short-term headwinds to persist in Europe, particularly the UK. However, he also sees scope for growth as spending on education, prisons, healthcare and aged care improves and direct exports continue to expand.
James Halstead is not immune from wider macro pressures. Nevertheless, its operating margin, dividend record and cash generation over the past decade demonstrate that its earnings are less cyclical than those of peers. And the dividend continues to grow, so investors are being paid to wait for a recovery.
Disclaimer: The author James Crux has a personal interest in Likewise.
